NF (neurofibromatosis or schwannomatosis) is now eligible for two Department of Defense (DoD) research funding programs. These are competitive, cross-disease funding pools – and we strongly encourage NF researchers to apply.
Click to download flier
Peer-Reviewed Medical Research Program (PRMRP)
NF has been added to the PRMRP, a $150 million funding pool supporting a broad range of medical research areas. Two major award mechanisms are now open:
Technology/Therapeutic Development Award (TTDA)
Clinical Trial Award (CTA)
Deadlines:
Pre-Application (Letter of Intent): June 9, 2025
Full Application: July 21, 2025, 11:59 p.m. ET
Learn more and apply: PRMRP Funding Opportunities
Rare Cancers Research Program (RCRP)
NF-related tumors may also qualify under the RCRP, which focuses on rare cancers. The following award mechanisms are available:
Idea Development Award (IDA)
Pre-Application (Pre-proposal): July 1, 2025
Full Application: October 6, 2025
Concept Award (CA)
Pre-Application (Letter of Intent): July 22, 2025
Full Application: August 26, 2025
Resource and Community Development Award (RCDA)
Pre-Application (Pre-proposal): July 1, 2025
Full Application: October 6, 2025
Learn more and apply: RCRP Funding Opportunities
We continue to fight for the restoration of dedicated NF research funding in the CDMRP (Congressionally Directed Medical Research Programs) for FY26 – but don’t miss these critical opportunities to fund your research and keep NF in the federal funding spotlight. Apply today.
